At a Senate hearing that considered her nomination to the post of NIH director, Monica Bertagnolli laid out an agenda that includes expanding access to clinical trials and making health care innovation affordable and accessible to the public.
The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).
